NCT03063073 2026-02-12
pec's
South Egypt Cancer Institute
Phase 3 Completed
Clinical Trials
4 trialsNCT04584853 2026-01-14
POETIC-A
Institute of Cancer Research, United Kingdom
Phase 3 Active not recruiting
NCT05016349 2021-08-23
Investigating the Potential Role of a Novel Quadrate Combination Therapy Mifepristone(Antiprogestrone), Tamoxifen, Retinoic Acid and Cannabidiol ( Selective Cyp 26 Inhibitor) for Treating Early Breast Cancer.
Kafrelsheikh University
Phase 3 Unknown
NCT03381417 2018-01-02
Nanogen Pegcyte Clinical Study for the Prevention of CIN in Breast-cancer Patients.
Nanogen Pharmaceutical Biotechnology Joint Stock Company
Phase 3 Completed